Skip to main content
. 2019 Jan 15;10(3):130–138. doi: 10.1159/000496172

Table 4.

Summary of clinical features in KBG patients in our study and the literature

Our study
Literature
Total
total mutation deletion total mutation deletion total mutation deletion
Cases 12 (100) 9 (75.0) 3 (25.0) 183 (100) 130 (71.0) 53 (29.0) 195 (100) 139 (71.3) 56 (28.7)

Gender
 Male 8/12 (66.7) 6/9 (66.7) 2/3 (66.7) 101/166 (61.0) 72/121 (59.5) 29/45 (64.4) 109/178 (61.2) 78/130 (60.0) 31/48 (65.0)
 Female 4/12 (33.3) 3/9 (33.3) 1/3 (33.3) 65/166 (39.0) 49/121 (40.5) 16/45 (35.6) 69/178 (38.8) 52/128 (40.0) 17/48 (35.0)
 Unknown 17/183 (9.3) 9/130 (6.9) 8/53 (15.1) 17/195 (8.7) 9/139 (6.5) 8/56 (14.3)

Short stature 9/12 (75.0) 8/9 (88.9) 1/3 (33.3) 102/177 (57.6) 79/127 (62.2) 23/50 (46.0) 111/189 (58.7) 87/136 (64.0) 24/53 (45,3)

Craniofacial dysmorphism 12/12 (100) 9/9 (100) 3/3 (100) 168/170 (98.8) 116/117 (99.1) 52/53 (98.1) 180/182 (98.9) 125/126 (99.2) 55/56 (98.2)
Typical facial gestalt 12/12 (100) 9/9 (100) 3/3 (100) 156/181 (86.2) 105/128 (82.0) 51/53 (96.2) 168/193 (87.0) 114/137 (83.2) 54/56 (96.4)
Long protuberant philtrum 12/12 (100) 9/9 (100) 3/3 (100) 92/149 (61.7) 69/108 (63.9) 23/41 (56.1) 104/161 (64.6) 78/117 (66.7) 26/44 (59.1)
Nose anomalies 12/12 (100) 9/9 (100) 3/3 (100) 134/165 (81.2) 97/120 (80.8) 37/45 (82.2) 146/177 (82.5) 106/129 (82.2) 40/48 (83.3)
Oral findings 12/12 (100) 9/9 (100) 3/3 (100) 108/154 (70.1) 75/109 (68.8) 33/45 (73.3) 120/166 (72.3) 84/118 (71.2) 36/48 (75.0)
Large and prominent ears 12/12 (100) 9/9 (100) 3/3 (100) 92/127 (72.4) 74/99 (74.7) 18/28 (64.3) 104/139 (74.8) 83/108 (76.9) 21/31 (67.7)
Macrodontia 12/12 (100) 9/9 (100) 3/3 (100) 121/143 (84.6) 95/108 (88.0) 26/35 (74.3) 133/154 (86.3) 104/117 (88.9) 29/37 (78.3)

Skeletal anomalies 12/12 (100) 9/9 (100) 3/3 (100) 79/105 (75.2) 61/77 (79.2) 18/28 (64.3) 91/117 (77.8) 70/86 (81.4) 21/31 (67.7)
Delayed bone age 10/12 (83.3) 7/9 (77.8) 3/3 (100) 43/86 (50.0) 34/63 (54.0) 9/23 (39.1) 54/98 (55.1) 42/72 (58.3) 12/26 (46.2)
Costovertebral anomalies 11/12 (91.6) 8/9 (88.8) 3/3 (100) 22/105 (21.0) 21/79 (26.6) 1/26 (3.8) 33/117 (28.2) 28/88 (31.8) 4/29 (13.7)
Spine anomalies 8/12 (66.7) 7/9 (77.8) 1/3 (33.3) 20/86 (23.3) 13/60 (21.7) 7/26 (26.9) 28/98 (28.6) 20/69 (29.0) 8/29 (27.6)
Joint stiffness 11/12 (91.6) 8/9 (88.8) 3/3 (100) 6/27 (22.2) 3/16 (18.8) 3/11 (27.3) 17/39 (43.5) 11/25 (44.0) 6/14 (42.9)

Hand anomalies 12/12 (100) 9/9 (100) 3/3 (100) 126/166 (75.9) 93/119 (78.2) 33/47 (70.2) 138/178 (77.5) 102/128 (79.7) 36/50 (72.0)

Neurological involvement 12/12 (100) 9/9 (100) 3/3 (100) 175/180 (97.2) 124/128 (96.9) 51/52 (98.1) 187/192 (97.4) 133/137 (97.1) 54/55 (98.2)
Developmental delay 10/12 (83.3) 7/9 (77.8) 3/3 (100) 140/178 (78.7) 96/129 (74.4) 44/49 (89.8) 150/190 (78.9) 103/138 (74.6) 47/52 (90.4)
Intellectual disability 10/12 (83.3) 7/9 (77.8) 3/3 (100) 157/173 (90.7) 113/124 (91.1) 44/49 (89.8) 167/185 (90.3) 120/133 (90.2) 47/52 (90.4)
Behavioral features 12/12 (100) 9/9 (100) 3/3 (100) 104/168 (61.9) 81/119 (68.1) 23/49 (46.9) 116/180 (64.4) 90/128 (70.3) 26/52 (50.0)
Epilepsy/convulsion 3/7 (42.8) 3/4 (75.0) 0/3 (0) 52/173 (30.1) 39/124 (31.5) 13/49 (26.5) 55/180 (30.5) 42/128 (32.8) 13/52 (25.0)
EEG anomalies 3/7 (42.8) 3/4 (75.0) 0/3 (0) 61/122 (50.0) 45/81 (55.5) 15/40 (37.5) 64/128 (50.0) 48/85 (56.5) 15/43 (34.9)
Brain imaging anomalies 8/10 (80.0) 6/8 (75.0) 2/2 (100) 36/84 (42.9) 19/56 (33.9) 17/28 (60.7) 44/94 (46.8) 25/64 (39.0) 19/30 (63.3)

Values represent number of cases with percentages in parentheses.